China · Delayed Price · Currency is CNY Daan Gene Statistics
Total Valuation
Daan Gene has a market cap or net worth of CNY 7.41 billion. The enterprise value is 6.66 billion.
| Market Cap | 7.41B |
| Enterprise Value | 6.66B |
Important Dates
The last earnings date was Saturday, August 29, 2026.
| Earnings Date | Aug 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Daan Gene has 1.40 billion shares outstanding. The number of shares has decreased by -1.21% in one year.
| Current Share Class | 1.40B |
| Shares Outstanding | 1.40B |
| Shares Change (YoY) | -1.21% |
| Shares Change (QoQ) | -9.21% |
| Owned by Insiders (%) | 2.02% |
| Owned by Institutions (%) | 5.71% |
| Float | 931.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.92 |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.12 |
| P/FCF Ratio | 34.34 |
| P/OCF Ratio | 20.83 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 30.85 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.57 |
| Interest Coverage | -116.87 |
Financial Efficiency
Return on equity (ROE) is -9.39% and return on invested capital (ROIC) is -7.78%.
| Return on Equity (ROE) | -9.39% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -7.78% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.67% |
| Revenue Per Employee | 495,959 |
| Profits Per Employee | -453,256 |
| Employee Count | 1,506 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Daan Gene has paid 44.46 million in taxes.
| Income Tax | 44.46M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.39% in the last 52 weeks. The beta is 0.45, so Daan Gene's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -18.39% |
| 50-Day Moving Average | 5.43 |
| 200-Day Moving Average | 5.98 |
| Relative Strength Index (RSI) | 42.17 |
| Average Volume (20 Days) | 24,135,963 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Daan Gene had revenue of CNY 746.91 million and -682.60 million in losses. Loss per share was -0.50.
| Revenue | 746.91M |
| Gross Profit | 88.29M |
| Operating Income | -489.19M |
| Pretax Income | -670.40M |
| Net Income | -682.60M |
| EBITDA | -261.48M |
| EBIT | -489.19M |
| Loss Per Share | -0.50 |
Balance Sheet
The company has 1.10 billion in cash and 123.29 million in debt, with a net cash position of 979.10 million or 0.70 per share.
| Cash & Cash Equivalents | 1.10B |
| Total Debt | 123.29M |
| Net Cash | 979.10M |
| Net Cash Per Share | 0.70 |
| Equity (Book Value) | 7.27B |
| Book Value Per Share | 5.02 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 355.82 million and capital expenditures -140.02 million, giving a free cash flow of 215.80 million.
| Operating Cash Flow | 355.82M |
| Capital Expenditures | -140.02M |
| Depreciation & Amortization | 227.71M |
| Net Borrowing | 19.08M |
| Free Cash Flow | 215.80M |
| FCF Per Share | 0.15 |
Margins
Gross margin is 11.82%, with operating and profit margins of -65.49% and -91.39%.
| Gross Margin | 11.82% |
| Operating Margin | -65.49% |
| Pretax Margin | -89.76% |
| Profit Margin | -91.39% |
| EBITDA Margin | -35.01% |
| EBIT Margin | -65.49% |
| FCF Margin | 28.89% |
Dividends & Yields
Daan Gene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.21% |
| Shareholder Yield | 1.21% |
| Earnings Yield | -9.21% |
| FCF Yield | 2.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 19, 2021. It was a forward split with a ratio of 1.6.
| Last Split Date | May 19, 2021 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |